135 related articles for article (PubMed ID: 38193603)
21. Adipose distribution patterns as prognostic factors in patients with HCC: A systematic review and meta-analysis.
Shi S; Yi H; Zheng Y; Zhao Y; Yu D
Eur J Radiol; 2023 Oct; 167():111025. PubMed ID: 37634440
[TBL] [Abstract][Full Text] [Related]
22. Surgical strategy for hepatocellular carcinoma originating in the caudate lobe.
Yamamoto T; Kubo S; Shuto T; Ichikawa T; Ogawa M; Hai S; Sakabe K; Tanaka S; Uenishi T; Ikebe T; Tanaka H; Kaneda K; Hirohashi K
Surgery; 2004 Jun; 135(6):595-603. PubMed ID: 15179365
[TBL] [Abstract][Full Text] [Related]
23. Caudate lobe resection for hepatocellular carcinoma.
Wahab MA; Fathy O; Elhanafy E; Atif E; Sultan AM; Salah T; Elshoubary M; Anwar N; Sultan A
Hepatogastroenterology; 2011; 58(112):1904-8. PubMed ID: 22024060
[TBL] [Abstract][Full Text] [Related]
24. Surgery for hepatocellular carcinoma located in the caudate lobe.
Sakoda M; Ueno S; Kubo F; Hiwatashi K; Tateno T; Kurahara H; Mataki Y; Shinchi H; Natsugoe S
World J Surg; 2009 Sep; 33(9):1922-6. PubMed ID: 19582505
[TBL] [Abstract][Full Text] [Related]
25. A Systematic Review and Network Meta-Analysis to Evaluate the Comparative Efficacy of Interventions for Unfit Patients with Chronic Lymphocytic Leukemia.
Städler N; Shang A; Bosch F; Briggs A; Goede V; Berthier A; Renaudin C; Leblond V
Adv Ther; 2016 Oct; 33(10):1814-1830. PubMed ID: 27535291
[TBL] [Abstract][Full Text] [Related]
26. Highlights for α-fetoprotein in determining prognosis and treatment monitoring for hepatocellular carcinoma.
Xu XS; Qu K; Liu C; Zhang YL; Liu J; Song YZ; Zhang P; Liu SN; Chang HL
World J Gastroenterol; 2012 Dec; 18(48):7242-50. PubMed ID: 23326129
[TBL] [Abstract][Full Text] [Related]
27. The efficacy of sorafenib in preventing hepatocellular carcinoma recurrence after resection: a systematic review and meta-analysis.
Li Z; Gao J; Zheng SM; Wang Y; Xiang X; Cheng Q; Zhu J
Rev Esp Enferm Dig; 2020 Mar; 112(3):201-210. PubMed ID: 32022577
[TBL] [Abstract][Full Text] [Related]
28. Systematic review of outcomes and meta-analysis of risk factors for prognosis after liver resection for hepatocellular carcinoma without cirrhosis.
Xie QS; Chen ZX; Zhao YJ; Gu H; Geng XP; Liu FB
Asian J Surg; 2021 Jan; 44(1):36-45. PubMed ID: 32988708
[TBL] [Abstract][Full Text] [Related]
29. The Impact of Imaging-Diagnosed Sarcopenia on Long-term Prognosis After Curative Resection for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
Kong Q; Gao Q; Li W; Chen Z
Acad Radiol; 2024 Apr; 31(4):1272-1283. PubMed ID: 38071101
[TBL] [Abstract][Full Text] [Related]
30. Comparison Between Wedge Resection and Lobectomy/Segmentectomy for Early-Stage Non-small Cell Lung Cancer: A Bayesian Meta-analysis and Systematic Review.
Shi Y; Wu S; Ma S; Lyu Y; Xu H; Deng L; Chen X
Ann Surg Oncol; 2022 Mar; 29(3):1868-1879. PubMed ID: 34613537
[TBL] [Abstract][Full Text] [Related]
31. The role of neoadjuvant conventional transarterial chemoembolization with radiofrequency ablation in the treatment of recurrent hepatocellular carcinoma after initial hepatectomy with microvascular invasion.
Peng Z; Wu X; Li J; Pang H; Zhang Y; Lin M; Wang Z; Xiao H; Li B; Chen M; Feng S; Kuang M; Chen S
Int J Hyperthermia; 2022; 39(1):688-696. PubMed ID: 35469522
[TBL] [Abstract][Full Text] [Related]
32. Efficacy comparison of radiofrequency ablation and hepatic resection for hepatocellular carcinoma: A meta-analysis.
Changyong E; Wang D; Yu Y; Liu H; Ren H; Jiang T
J Cancer Res Ther; 2017; 13(4):625-630. PubMed ID: 28901304
[TBL] [Abstract][Full Text] [Related]
33. Treatment of solitary hepatocellular carcinoma up to 2 cm: A PRISMA-compliant systematic review and meta-analysis.
Fan H; Zhou C; Yan J; Meng W; Zhang W
Medicine (Baltimore); 2020 Jun; 99(23):e20321. PubMed ID: 32501978
[TBL] [Abstract][Full Text] [Related]
34. Surgical outcome of patients with hepatocellular carcinoma originating in the caudate lobe.
Tanaka S; Shimada M; Shirabe K; Maehara S; Tsujita E; Taketomi A; Maehara Y
Am J Surg; 2005 Sep; 190(3):451-5. PubMed ID: 16105535
[TBL] [Abstract][Full Text] [Related]
35. [Hepatic resection for a single hepatocellular carcinoma in the caudate lobe].
Hayashi H; Beppu T; Masuda T; Okabe H; Komori H; Horino K; Ishiko T; Takamori H; Hirota M; Baba H
Gan To Kagaku Ryoho; 2007 Nov; 34(12):2090-2. PubMed ID: 18219908
[TBL] [Abstract][Full Text] [Related]
36. Survival analysis between laparoscopic and open hepatectomy for hepatocellular carcinoma: a meta-analysis based on reconstructed time-to-event data.
Sun Q; Zhang X; Gong X; Hu Z; Zhang Q; He W; Chang X; Hu Z; Chen Y
Hepatol Int; 2021 Oct; 15(5):1215-1235. PubMed ID: 34258665
[TBL] [Abstract][Full Text] [Related]
37. Survival comparison between radiofrequency ablation and surgical resection for patients with small hepatocellular carcinoma: A systematic review and meta-analysis.
Xuan D; Wen W; Xu D; Jin T
Medicine (Baltimore); 2021 Feb; 100(7):e24585. PubMed ID: 33607788
[TBL] [Abstract][Full Text] [Related]
38. Does adjuvant hepatic artery infusion chemotherapy improve patient outcomes for hepatocellular carcinoma following liver resection? A meta-analysis.
Hu L; Zheng Y; Lin J; Shi X; Wang A
World J Surg Oncol; 2023 Apr; 21(1):121. PubMed ID: 37013589
[TBL] [Abstract][Full Text] [Related]
39. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of soluble programmed cell death-1 (sPD-1) and soluble programmed cell death ligand-1 (sPD-L1) for hepatocellular carcinoma: a systematic review and meta-analysis.
Xue JS; Liu H; Meng GX; Ding ZN; Yan LJ; Yao SY; Li HC; Dong ZR; Chen ZQ; Hong JG; Li T
Cancer Immunol Immunother; 2022 Jul; 71(7):1633-1644. PubMed ID: 34750662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
